USPTO serial 85159052
REGENOKINE
Reviewed by CopyMark Law Group
Reg. 4055150Status 710
- Filing date
- Status date
- Registration date
- Nov 15, 2011
- Examiner
- HESIK, APRIL ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with REGENOKINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Duesseldorf, DE
Duesseldorf, DE
Duesseldorf, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan B. Flohr
SUSAN B. FLOHR BLANK ROME LLP1825 Eye Street NWWASHINGTON, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical therapeutic preparations for treatment of joints, muscles, nerves, ligaments, cartilage and bones; dermatological preparations and substances for medical purposes; sanitary preparations for medical purposes | SECTION 8 - CANCELLED | — |
| 010 | Instruments, devices and apparatus for drawing, processing and storage of blood or blood preparations in the medical sector, in particular comprising syringes, blood bags, cannulas | SECTION 8 - CANCELLED | — |
| 042 | Research and development of medicinal products, in particular medical devices and injectable substances; Research and development of DNA-based diagnostic tests for rheumatoid diseases and diseases of the locomotor system; Research and development by cloning and expression of genes; Research, development and analysis of the medical effect of substances, including natural substances, on disease relevant parameters for diseases of the locomotor system and the nervous system; Research and development with/on cytokine and preparations containing cytokine for treating diseases of the locomotor system and of the nervous system | SECTION 8 - CANCELLED | — |
| 044 | Medical assistance and hygienic care, in particular in the field of treating diseases of the locomotor system, the nervous system and the immune system; conducting and analysis of DNA-based diagnostic tests for rheumatoid diseases and diseases of the locomotor system; medical treatment with cytokine and preparations containing cytokine for treating diseases of the locomotor system and the nervous system | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Orthogen AG
- Other trademarks owned by Orthogen AG
- Other trademarks owned by Orthogen AG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named REGENOKINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 15, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 25, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 30, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 30, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 27, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 26, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 26, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 26, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 26, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 20, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 11, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jun 23, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 23, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2010 | NWAP | NEW APPLICATION ENTERED | — |